Skip to main content
T

Trasis

Trasis designs and manufactures high-performance synthesizers and dose preparation equipment for the production of radiolabelled therapeutic and diagnostic substances in nuclear medicine. By providing customized synthetic methods and regulatory support, Trasis enables faster access to GMP-compliant Active Pharmaceutical Ingredients, streamlining the transition from drug development to market.

Rixensart, BelgiumFounded 200432010K+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

The production of radiolabelled therapeutic and diagnostic substances for nuclear medicine requires specialized equipment and expertise, often posing a bottleneck in drug development and access to GMP-compliant Active Pharmaceutical Ingredients (APIs). Traditional synthesis methods can be time-consuming, complex, and may lack the necessary regulatory support for efficient translation from research to clinical application.

Solution

Trasis designs and manufactures high-performance synthesizers and dose preparation equipment tailored for the efficient production of radiopharmaceuticals used in nuclear medicine. Their product line includes versatile synthesizers for PET tracers, theranostic applications, and radiometal labeling, as well as integrated quality control systems and hospital dispensing solutions. By offering customized synthetic methods and comprehensive regulatory support, Trasis streamlines the transition from drug development to market, enabling faster access to GMP-compliant APIs. Their equipment and support services are designed to be adaptable to specific project requirements, fostering collaboration and ensuring successful outcomes in radiopharmacy.

Target Audience

Trasis primarily serves radiopharmacies, hospitals, research institutions, and pharmaceutical companies involved in the development, production, and distribution of radiopharmaceuticals for diagnostic imaging and therapeutic applications.

Features

  • AllinOne: A comprehensive synthesis solution suitable for research labs and radiopharmacy networks.
  • miniAllinOne: A synthesizer specifically designed for theranostic applications.
  • EasyOne: A cost-effective and user-friendly solution for radiometal labeling.
  • Unidose: A hospital dispensing system for radiopharmaceuticals.
  • QC 1: A compact and integrated quality control system streamlining typical PET tracer QC.
  • Customized synthetic method development and optimization.
  • Regulatory support to ensure GMP compliance.
This profile is AI-generated and may contain inaccuracies.